Mary-Ellen Taplin

9PUBLICATIONS
184CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 24, 2026
A Phase 2 Study of Berzosertib in Combination with Carboplatin compared to Docetaxel with Carboplatin in Metastatic Castration-Resistant Prostate Cancer.

|Aug 06, 2026
Systemic Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer: ASCO Living Guideline, Version 2026.1.4.

|Jun 01, 2026
Perioperative Apalutamide in High-Risk Localized Prostate Cancer.

|May 11, 2026
Immune Spatial Organization Predicts Distant Metastasis Risk in Aggressive Localized Prostate Cancer.

|Nov 20, 2025
Accelerating Drug Development in Hormone-Naïve Prostate Cancer through Multimodal Therapy Strategies: The MetaCURE Phase 2 Randomized Clinical Trial.

Deaglan McHugh, Matthew Dallos, Min Yuen Teo

|Aug 12, 2025
Increased ErbB2 Signaling Is an Early Adaptation to Androgen Signaling Inhibition and Persists in Castration-Resistant Prostate Cancer.

Jude Owiredu, Betul Ersoy-Fazlioglu, Larysa Poluben

Pageof 2

Frequent Collaborators

4 joint publications

David J Einstein

3 joint publications

Atish D Choudhury

3 joint publications

Amanda Pace

3 joint publications

Eliezer M Van Allen